A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome
Clinical Genetics · 2026-08 · 110 (2) · 139-149
DOI: 10.1111/cge.70190 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Genetics, online erschienen am 31.05.2026. Verfasst von Andrew Courtwright und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, University of Utah Health, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Telomere, Telomere Shortening. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pathogenic genetic variants in telomere maintenance genes can lead to accelerated telomere length (TL) shortening. Individuals can pass on significantly shortened TL to their offspring, with or without transmission of the causal genetic variant. Carriers and their progeny are at increased risk for disease in organ systems with high life‐time replicative demand, including bone marrow, lungs, and liver. The diagnosis of short telomere related disease is complicated by three factors: the potential for TL inheritance independent of genotype; organ‐specific manifestations that evolve across the lifespan; and the lack of a TL cutoff that reliably predicts phenotypic disease. In this manuscript, we suggest that short telomere syndrome (STS) rather than telomere biology disorder (TBD) is the appropriate term for these diseases. We propose a phenotype‐based approach to STS that distinguishes among four groups: (1) STS (TL < 10th age adjusted percentile in PBMCs with multiple phenotypic manifestations); (2) short telomeres with one phenotypic manifestation; (3) short telomeres without phenotypic manifestations; and (4) multiple phenotypic manifestations without short telomeres. This approach is intended to guide clinical evaluation of patients with short telomeres and longitudinal risk stratification. We also identify research priorities needed to refine diagnostic thresholds and align TL interpretation with disease biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, University of Utah Health, Salt Lake City, Utah, USA.
- University of Utah Health, Salt Lake City, Utah, USA.
- Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
- Division of Gastroenterology, Hepatology, and Nutrition, University of Utah Health, Salt Lake City, Utah, USA.
- Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Andrew Courtwright
Zitieren
APA
Courtwright, A., King, R. A., Vagher, J., Levy, C. T., Orozco, J. G. F., Batista, L. F., Osman, A., Tantavahi, S., & Scholand, M. B. (2026). A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome. Clinical Genetics, 110(2), 139-149. https://doi.org/10.1111/cge.70190
Vancouver
Courtwright A, King RA, Vagher J, Levy CT, Orozco JGF, Batista LF, et al. A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome. Clinical Genetics. 2026;110(2):139-149. doi:10.1111/cge.70190
BibTeX
@article{Courtwright2026,
author = {Courtwright, Andrew and King, Richard A and Vagher, Jennie and Levy, Cate T and Orozco, Juan Gallegos F and Batista, Luis Fz and Osman, Afaf and Tantavahi, Srinivas and Scholand, Mary Beth},
title = {A Proposed Clinical Diagnostic Framework for Short Telomere Syndrome},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {2},
pages = {139--149},
doi = {10.1111/cge.70190}
}
EUVIMED